Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning

Hariharan Shanmugam, Aaron S. Kesselheim, Ian T. T. Liu, William B. Feldman, Benjamin N. Rome

Open source

DOI
10.1001/jamanetworkopen.2026.14274
Published
2026-05-22
Container
JAMA Network Open
Publisher
American Medical Association (AMA)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2026.14274,
  title = {Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning},
  author = {Hariharan Shanmugam and Aaron S. Kesselheim and Ian T. T. Liu and William B. Feldman and Benjamin N. Rome},
  year = {2026},
  journal = {JAMA Network Open},
  doi = {10.1001/jamanetworkopen.2026.14274},
  url = {https://doi.org/10.1001/jamanetworkopen.2026.14274}
}

RIS

TY  - JOUR
TI  - Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning
AU  - Hariharan Shanmugam
AU  - Aaron S. Kesselheim
AU  - Ian T. T. Liu
AU  - William B. Feldman
AU  - Benjamin N. Rome
PY  - 2026
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.14274
UR  - https://doi.org/10.1001/jamanetworkopen.2026.14274
ER  - 

APA

Shanmugam, H., Kesselheim, A. S., Liu, I. T. T., Feldman, W. B., & Rome, B. N. (2026). Changes in the Use of Montelukast for Asthma After a US Food and Drug Administration Boxed Warning. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2026.14274

Source records